Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Price:
73.46 CNY
0.62%
Market Closed
Updated:
May 16, 2024
P/E
Price to Earnings
Price to Earnings
-13.7
Current
5
Median
23.9
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-13.7
Market Cap
/
4.3B
Net Income
-314.3m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
4.3B CNY | -13.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
39.8B CHF | 45.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.8T JPY | 40.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
188.3B DKK | 38.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
21.1B USD | 45.6 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.5B USD | 66.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
12.3T KRW | -65 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.5B CNY | 33.9 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.5B GBP | 53.1 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | -61.8 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 12 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
